Browse our collection of papers in
GlaxoSmithKline (GSK)
C/B/2111. Corporate social responsibility in pharmaceutical industry: case study of GlaxoSmithKline
- WORDS:
- 1000
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper describes the environment of the pharmaceutical industry highlighting its challenges and threats, addressing the issues of corporate social responsibility (CSR) faced by pharmaceutical companies, and examining the mission of GlaxoSmithKline (GSK) with regard to their CSR implementation.
KEYWORDS: pharmaceutical industry, GlaxoSmithKline, GSK, corporate social responsibility, CSR,
Other Papers On: Corporate Social Responsibility
Other Papers On: Pharmaceutical Industry
Other Papers On: GlaxoSmithKline (GSK)
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
Keywords Tag Cloud
glaxosmithkline gsk management merger dissertation pharmaceutical mergers change strategic om plc performance glaxo beecham financial wellcome corporate operations smithkline desired bring acquisition study effects proposal market system social stock strategy glaxowellcome quality value global vs organisational astrazeneca managing johnson impact model equilibrium technical newspaper construction disclosures environmental glaxosmithklein publicity using british pre pharmaceuticals acquisitions petroleum post smithline prediction annual pestel stocks swine intelligence safety clinical molecular shoeshine directions novartis pfizer companies audit innovation vaccines flu portfolio production uk healthcare responsibility faced issues reports control implementation valuation development role lean price critical process speeding share innovations intellectual systems soft critique knowledge methodology harbin project property negotiation approach backgrounds entrepreneurship announcement effect master return glaxosmithklines final culture benefit economic finance international risk c comparative benefits current position investigation overview options company
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
Thank you very much excellent service.Tony
